Jiangsu Hengrui’s SHR-A2102 Earns Breakthrough Therapy Designation for Urothelial Carcinoma
Jiangsu Hengrui Pharmaceuticals Co., Ltd (SHA: 600276) has announced that it has received breakthrough therapy...
Company
Roche’s Columvi Supplemental sBLA Accepted by FDA for Relapsed DLBCL Treatment
Swiss pharmaceutical giant Roche (SWX: ROG) has announced that the US Food and Drug Administration...
Teva Pharmaceutical to Divest Holdings in Teva Takeda Pharma to JKI
Israel-based Teva Pharmaceutical Industries Ltd (NYSE: TEVA) has announced its intention to sell all holdings...
Eyebright Medical Technology Aims to Raise RMB 300 Million for Contact Lens Production Expansion
China-based ophthalmic medical device manufacturer, Eyebright Medical Technology Co., Ltd (SHA: 688050), has announced plans...
Cambrex Partners with Eli Lilly to Enhance Clinical Development for Biotech Collaborators
US-based contract development and manufacturing organization (CDMO) Cambrex has reached an agreement with Eli Lilly...
Dewpoint Therapeutics Partners with Mitsubishi Tanabe Pharma to Develop ALS Treatment
US-based Dewpoint Therapeutics Inc. has entered into a strategic partnership with Japan-headquartered Mitsubishi Tanabe Pharma...
AstraZeneca’s Imfinzi Receives FDA Approval for Limited-Stage Small Cell Lung Cancer
UK-based pharmaceutical giant AstraZeneca (AZ, NASDAQ: AZN) has reported receiving a new indication approval from...
Eli Lilly & Co. Expands Wisconsin Manufacturing Facility with $3 Billion Investment
US pharmaceutical major Eli Lilly & Co. (NYSE: LLY) has announced the expansion of its...
Amgen Expands Biomanufacturing Footprint in North Carolina with Second Facility
US biotech company Amgen (NASDAQ: AMGN) has announced plans to construct a second drug substance...
Merck Initiates Phase III MOVE-NOW Study for Lagevrio COVID-19 Antiviral
US pharmaceutical giant Merck & Co., Inc. (NYSE: MRK) has announced the commencement of the...
CDE Approves RinuaGene’s mRNA-Based RG002 for Clinical Study in Cervical Dysplasia
China’s Center for Drug Evaluation (CDE) of the National Medical Products Administration (NMPA) has indicated...
Burning Rock Ltd Reports Q3 2024 Financials with Revenue Growth and R&D Reduction
China-based medtech firm Burning Rock Ltd (NASDAQ: BNR) has released its financial results for the...
Novavax to Sell Czech Manufacturing Facility to Novo Nordisk for $200 Million
US-based Novavax, Inc. (NASDAQ: NVAX) has reached an agreement to sell its manufacturing facility located...
Eli Lilly’s Zepbound Outperforms Wegovy in SURMOUNT-5 Weight Loss Study
US pharmaceutical major Eli Lilly & Co., (NYSE: LLY) has revealed a positive readout from...
Phanes Therapeutics’ PT217 Earns FDA Fast Track Designation for Neuroendocrine Prostate Cancer
Sino-US biotech company Phanes Therapeutics Inc. has announced that it has received another Fast Track...
CGeneTech’s Cetagliptin Receives NMPA Approval for Type 2 Diabetes Treatment in China
The National Medical Products Administration (NMPA) in China has indicated on its website that CGeneTech...
Eisai and Biogen’s Leqembi Approved in Mexico for Early Alzheimer’s Disease Treatment
Eisai Co., Ltd (TYO: 4523) and Biogen Inc. (NASDAQ: BIIB) have announced that their co-developed...
AstraZeneca Appoints Iskra Reic as EVP, International, Amid Leon Wang’s Investigation in China
AstraZeneca (AZ, NASDAQ: AZN), a leading UK pharmaceutical company, has announced the appointment of Iskra...
Shanghai Escugen Receives NMPA Approval for Second Phase III Trial of ESG401 in TNBC
Shanghai Escugen, a China-based biopharmaceutical company, has announced receiving the green light from the National...
Johnson & Johnson Submits sBLAs to FDA for Tremfya Indications in Pediatric Psoriasis and Arthritis
Global healthcare giant Johnson & Johnson (J&J; NYSE: JNJ) has announced the submission of two...